93 related articles for article (PubMed ID: 1597732)
1. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Vera DR; Stadalnik RC; Krohn KA
J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
5. Deferoxamine, a promising bifunctional chelating agent for labeling proteins with gallium: Ga-67 DF-HSA: concise communication.
Yokoyama A; Ohmomo Y; Horiuchi K; Saji H; Tanaka H; Yamamoto K; Ishii Y; Torizuka K
J Nucl Med; 1982 Oct; 23(10):909-14. PubMed ID: 7119886
[TBL] [Abstract][Full Text] [Related]
6. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
7. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
Hashmi M; Rosebrough SF
Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
[TBL] [Abstract][Full Text] [Related]
9. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Vera DR; Woodle ES; Stadalnik RC
J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and comparative biodistribution of the desferrioxamine-human serum albumin (DF-HSA) conjugates prepared with various methods.
Jánoki GA; Harwig JF; Wolf W
J Nucl Med Allied Sci; 1988; 32(1):39-44. PubMed ID: 3404264
[No Abstract] [Full Text] [Related]
11. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
[TBL] [Abstract][Full Text] [Related]
12. Fluorine-18 labeled galactosyl-neoglycoalbumin for imaging the hepatic asialoglycoprotein receptor.
Yang W; Mou T; Peng C; Wu Z; Zhang X; Li F; Ma Y
Bioorg Med Chem; 2009 Nov; 17(21):7510-6. PubMed ID: 19796957
[TBL] [Abstract][Full Text] [Related]
13. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Mathias CJ; Wang S; Low PS; Waters DJ; Green MA
Nucl Med Biol; 1999 Jan; 26(1):23-5. PubMed ID: 10096497
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
17. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
18. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
[TBL] [Abstract][Full Text] [Related]
19. A novel radioiodination reagent for protein radiopharmaceuticals with L-lysine as a plasma-stable metabolizable linkage to liberate m-iodohippuric acid after lysosomal proteolysis.
Wakisaka K; Arano Y; Uezono T; Akizawa H; Ono M; Kawai K; Ohomomo Y; Nakayama M; Saji H
J Med Chem; 1997 Aug; 40(16):2643-52. PubMed ID: 9258371
[TBL] [Abstract][Full Text] [Related]
20. In vivo kinetics and thrombus accumulation of 67Ga-labeled urokinase.
Ohmomo Y; Yokoyama A; Yamauchi Y; Horiuchi K; Saji H; Tanaka C; Torizuka K
Int J Nucl Med Biol; 1985; 12(1):47-52. PubMed ID: 4008166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
